Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fratantoni

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Blood Cells|January 1, 1992
Review: the platelet storage lesion: possible role of plasticizers?J C Fratantoni
Progress in Clinical and Biological Research|January 1, 1983
Safety evaluation of hemoglobin solutionsJ C Fratantoni
Environmental Health Perspectives|November 1, 1982
Safety of DEHP: role of the bureau of biologicsJ C Fratantoni
Transfusion|April 29, 1999
The IND: what is it and who needs it? Investigational New DrugJ C Fratantoni
American Heart Journal|March 1, 1977
Thrombolytic therapyJ C Fratantoni
Biologicals : Journal of the International Association of Biological Standardization|November 13, 1998
Creutzfeldt-Jakob disease and blood products: FDA policyJ C Fratantoni
Transfusion|January 1, 1976
Status report on methods of platelet preservationJ C Fratantoni
Advances in Experimental Medicine and Biology|January 1, 1979
Urokinase as a cell productJ C Fratantoni
Transfusion|January 1, 1986
Comment on standardized procedures and the regulatory processJ C Fratantoni
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|March 4, 1999
Red blood cell substitutes: evolution of approaches to demonstrating efficacyJ C Fratantoni
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Blood Cells|January 1, 1992
Review: the platelet storage lesion: possible role of plasticizers?J C Fratantoni
Progress in Clinical and Biological Research|January 1, 1983
Safety evaluation of hemoglobin solutionsJ C Fratantoni
Environmental Health Perspectives|November 1, 1982
Safety of DEHP: role of the bureau of biologicsJ C Fratantoni
Transfusion|April 29, 1999
The IND: what is it and who needs it? Investigational New DrugJ C Fratantoni
American Heart Journal|March 1, 1977
Thrombolytic therapyJ C Fratantoni
Biologicals : Journal of the International Association of Biological Standardization|November 13, 1998
Creutzfeldt-Jakob disease and blood products: FDA policyJ C Fratantoni
Transfusion|January 1, 1976
Status report on methods of platelet preservationJ C Fratantoni
Advances in Experimental Medicine and Biology|January 1, 1979
Urokinase as a cell productJ C Fratantoni
Transfusion|January 1, 1986
Comment on standardized procedures and the regulatory processJ C Fratantoni
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|March 4, 1999
Red blood cell substitutes: evolution of approaches to demonstrating efficacyJ C Fratantoni
Pageof 5